Back to Journals » OncoTargets and Therapy » Volume 7

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

Total article views   Abstract views HTML views PDF downloads Totals
6,705 Dovepress* 4,722 1,264+ 1,157 5,986
PubMed Central* 0 719 344 719
Totals 4,722 1,983 1,501 6,705
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar